...
首页> 外文期刊>Acta biomaterialia >Hollow fibers of poly(lactide-co-glycolide) and poly(ε-caprolactone) blends for vascular tissue engineering applications.
【24h】

Hollow fibers of poly(lactide-co-glycolide) and poly(ε-caprolactone) blends for vascular tissue engineering applications.

机译:聚(丙交酯-共-乙交酯)和聚(ε-己内酯)的空心纤维可用于血管组织工程应用。

获取原文
获取原文并翻译 | 示例
           

摘要

At present the manufacture of small-diameter blood vessels is one of the main challenges in the field of vascular tissue engineering. Currently available vascular grafts rapidly fail due to development of intimal hyperplasia and thrombus formation. Poly(lactic-co-glycolic acid) (PLGA) hollow fiber (HF) membranes have previously been proposed for this application, but as we show in the present work, they have an inhibiting effect on cell proliferation and rather poor mechanical properties. To overcome this we prepared HF membranes via phase inversion using blends of PLGA with poly(ε-caprolactone) (PCL). The influence of polymer composition on the HF physicochemical properties (topography, water transport and mechanical properties) and cell attachment and proliferation were studied. Our results show that only the ratio PCL/PLGA of 85/15 (PCL/PLGA85/15) yielded a miscible blend after processing. A higher PLGA concentration in the blend led to immiscible PCL/PLGA phase-separated HFs with an inhomogeneous morphology and variation in the cell culture results. In fact, the PCL/PLGA85/15 blend, which had the most homogeneous morphology and suitable pore structure, showed better human adipose stem cell (hASC) attachment and proliferation compared with the homopolymers. This, combined with the good mechanical and transport properties, makes them potentially useful for the development of small-caliber vascular grafts.
机译:目前,小直径血管的制造是血管组织工程领域的主要挑战之一。由于内膜增生和血栓形成的发展,目前可用的血管移植物迅速失效。聚(乳酸-乙醇酸)(PLGA)中空纤维(HF)膜先前已提出用于该应用,但是正如我们在本工作中所显示的,它们对细胞增殖具有抑制作用,并且机械性能较差。为了克服这个问题,我们使用PLGA与聚(ε-己内酯)(PCL)的混合物通过相转化制备了HF膜。研究了聚合物组成对HF物理化学性质(形貌,水传输和机械性质)以及细胞附着和增殖的影响。我们的结果表明,加工后只有85/15的PCL / PLGA比(PCL / PLGA85 / 15)产生了可混溶的混合物。共混物中较高的PLGA浓度导致PCL / PLGA相分离的HF不混溶,形态和细胞培养结果均不均匀。实际上,与均聚物相比,具有最均一的形态和合适的孔结构的PCL / PLGA85 / 15共混物显示出更好的人脂肪干细胞(hASC)附着和增殖。结合良好的机械和运输性能,使其有可能用于小口径血管移植物的开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号